Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tahir Latif

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Clinical Lymphoma & Myeloma|December 16, 2005
Advances in multiple myeloma and spine diseaseTahir Latif, Mohamad A Hussein
Critical Reviews in Oncology/Hematology|April 5, 2014
Prophylactic CNS directed therapy in systemic diffuse large B cell lymphomaAbhimanyu Ghose, Ria Kundu, Tahir Latif
Translational Oncology|June 10, 2015
Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted NanovesiclesVictor M Blanco, Tahir Latif, Zhengtao Chu, et al.
Hematology Reports|December 21, 2011
The biology of myelodysplastic syndromes: unity despite heterogeneityAzra Raza, Raymond Cruz, Tahir Latif, et al.
Experimental Hematology & Oncology|December 6, 2012
Thalidomide and its analogues in the treatment of Multiple MyelomaTahir Latif, Nabeel Chauhan, Rashid Khan, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2015
Influence of Rituximab on Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma and Role of Prophylaxis--A Systematic Review of Prospective StudiesAbhimanyu Ghose, Harold Kunal Elias, Gunjan Guha, et al.
Investigational New Drugs|November 6, 2004
Phase II study of oral bis (aceto) ammine dichloro (cyclohexamine) platinum (IV) (JM-216, BMS-182751) given daily x 5 in hormone refractory prostate cancer (HRPC)Tahir Latif, Laura Wood, Cindy Connell, et al.
Journal of Gastrointestinal Oncology|May 18, 2023
Immune checkpoint inhibitors in liver transplant: a case seriesMark Rudolph, Shimul A Shah, Ralph Quillin, et al.
Blood Advances|November 12, 2021
Momelotinib is a highly potent inhibitor of FLT3-mutant AMLMohammad Azhar, Zachary Kincaid, Meenu Kesarwani, et al.
The Journal of Surgical Research|October 16, 2020
Evaluating the Impact of ESPAC-1 on Shifting the Paradigm of Pancreatic Cancer TreatmentLeah K Winer, Alexander R Cortez, Syed A Ahmad, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Clinical Lymphoma & Myeloma|December 16, 2005
Advances in multiple myeloma and spine diseaseTahir Latif, Mohamad A Hussein
Critical Reviews in Oncology/Hematology|April 5, 2014
Prophylactic CNS directed therapy in systemic diffuse large B cell lymphomaAbhimanyu Ghose, Ria Kundu, Tahir Latif
Translational Oncology|June 10, 2015
Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted NanovesiclesVictor M Blanco, Tahir Latif, Zhengtao Chu, et al.
Hematology Reports|December 21, 2011
The biology of myelodysplastic syndromes: unity despite heterogeneityAzra Raza, Raymond Cruz, Tahir Latif, et al.
Experimental Hematology & Oncology|December 6, 2012
Thalidomide and its analogues in the treatment of Multiple MyelomaTahir Latif, Nabeel Chauhan, Rashid Khan, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2015
Influence of Rituximab on Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma and Role of Prophylaxis--A Systematic Review of Prospective StudiesAbhimanyu Ghose, Harold Kunal Elias, Gunjan Guha, et al.
Investigational New Drugs|November 6, 2004
Phase II study of oral bis (aceto) ammine dichloro (cyclohexamine) platinum (IV) (JM-216, BMS-182751) given daily x 5 in hormone refractory prostate cancer (HRPC)Tahir Latif, Laura Wood, Cindy Connell, et al.
Journal of Gastrointestinal Oncology|May 18, 2023
Immune checkpoint inhibitors in liver transplant: a case seriesMark Rudolph, Shimul A Shah, Ralph Quillin, et al.
Blood Advances|November 12, 2021
Momelotinib is a highly potent inhibitor of FLT3-mutant AMLMohammad Azhar, Zachary Kincaid, Meenu Kesarwani, et al.
The Journal of Surgical Research|October 16, 2020
Evaluating the Impact of ESPAC-1 on Shifting the Paradigm of Pancreatic Cancer TreatmentLeah K Winer, Alexander R Cortez, Syed A Ahmad, et al.
Pageof 2